Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Testing a smart needle disposal container for people with hemophilia at home

Tests a smart needle disposal container in adults with hemophilia A or B.

Plain-language title generated from the registry record
Registry title: Study of a Smart Sharps Disposal Device in Patients With Hemophilia

Key facts

Where
Philadelphia, United StatesSee the 2 sites

Where in United States

  • Hospital of the University of PennsylvaniaPhiladelphia, United StatesNo longer taking part
  • Penn Blood Disorders ProgramPhiladelphia, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Pennsylvania
Trial code
NCT07421154
Record updated
9 July 2026
Original description
This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.Read full original descriptionShow less

Study of a Smart Sharps Disposal in Patients With Hemophilia

This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.

Inclusion:; Male or female, ≥18 years of age; Moderate or Severe Hemophilia A or B, with or without an inhibitor; Prescribed prophylaxis with either a factor product or emicizumab that is scheduled to be given at least once every 14 days; Exclusion:; Stated inability to use the SharpsCue container; Treatment with another investigational drug or other intervention during the study period; Patients on prophylactic dosing less than once every 14 days; Patients who are infused by a home nurse.

ClinicalTrials.gov NCT07421154